HEPION PHARMACEUTICALS, INC. Customer Advances, Current
HEPION PHARMACEUTICALS, INC. (HEPA) had Customer Advances, Current of $1.80 million as of 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Notes
us-gaap:CustomerAdvancesCurrent · last filed 2021-03-31
- 2020-12-31: Customer Advances, Current $1.80M.
- 2020-09-30: Customer Advances, Current $500.00K.
- 2020-06-30: Customer Advances, Current $400.00K.
- 2020-03-31: Customer Advances, Current $1.10M.
| Period end | Customer Advances, Current | Customer Advances, Current as first filed |
|---|---|---|
| 2020-12-31 | $1.80M 10-K · filed 2021-03-31 | |
| 2020-09-30 | $500.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $400.00K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $1.10M 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $400.00K 10-K · filed 2021-03-31 | |
| 2019-03-31 | $90.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $41.51K 10-K · filed 2020-05-14 | |
| 2018-09-30 | $46.98K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $45.82K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $32.32K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $41.51K 10-Q · filed 2019-05-15 | $32.90K 10-KT · filed 2018-03-26 |
| 2017-09-30 | $55.12K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $75.48K 10-KT · filed 2018-03-26 | |
| 2016-06-30 | $354.54K 10-KT · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |